Login / Signup

Initial eGFR Changes with SGLT2 Inhibitor in Patients With Type 2 Diabetes and Associations With the Risk of Abnormal Serum Potassium Level.

Yi-Wei KaoTze Fan ChaoShao-Wei ChenYu-Wen ChengYi-Hsin ChanPao-Hsien Chu
Published in: Journal of the American Heart Association (2024)
Physicians should be aware that the eGFR trough occurs shortly, and consequent serum potassium changes following SGLT2i initiation.
Keyphrases
  • small cell lung cancer
  • epidermal growth factor receptor
  • tyrosine kinase
  • primary care